Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks-Reference-Cited by-同舟云学术

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Published:2012-06 Issue:9835 Volume:379 Page:2439-2448
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sax Paul E,DeJesus Edwin,Mills Anthony,Zolopa Andrew,Cohen Calvin,Wohl David,Gallant Joel E,Liu Hui C,Zhong Lijie,Yale Kitty,White Kirsten,Kearney Brian P,Szwarcberg Javier,Quirk Erin,Cheng Andrew K

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Antiretroviral treatment of adults with HIV infection; 2010 Recommendations of the International AIDS Society-USA Panel;Thompson;JAMA,2010

2. Tenofovir disoproxil fumarate, emtricitabine and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients; 144-week analysis;Arribas;J Acquir Immune Defic Syndr,2008

3. Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV therapy;Sax;N Engl J Med,2009

4. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, noninferiority trial;Cohen;Lancet,2011

5. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial;Molina;Lancet,2011

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people with HIV with profound immunosuppression;HIV Medicine;2024-08-12

2. The differential effects of integrase strand transfer inhibitors and efavirenz on neuropsychiatric conditions and brain imaging in HIV-positive men who have sex with men;Biosafety and Health;2024-08

3. Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF versus elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial;The Lancet Regional Health - Western Pacific;2024-08

4. Effectiveness of integrase strand transfer inhibitors among treatment-naive people living with HIV/AIDS in Guangdong, China: A real-world, retrospective cohort study;Medicine;2024-06-07

5. Cardiac and Renal Comorbidities in Aging People Living With HIV;Circulation Research;2024-05-24